Bolt Biotherapeutics (BOLT) Insider Trading & Ownership $5.66 -0.09 (-1.48%) As of 11:31 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipShort InterestTrendsBuy This Stock Bolt Biotherapeutics (NASDAQ:BOLT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.10%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$1.25KNumber OfInsiders Selling(Last 12 Months)0 Get BOLT Insider Trade Alerts Want to know when executives and insiders are buying or selling Bolt Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BOLT Insider Buying and Selling by Quarter Bolt Biotherapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/16/2024Sarah NemecVPBuy125$10.00$1,250.00 (Data available from 1/1/2013 forward) BOLT Insider Trading Activity - Frequently Asked Questions Who is on Bolt Biotherapeutics' Insider Roster? The list of insiders at Bolt Biotherapeutics includes Edgar Engleman, Sarah Nemec, Vivo Capital Viii, Llc, and William P Quinn. Learn more on insiders at BOLT. What percentage of Bolt Biotherapeutics stock is owned by insiders? 6.10% of Bolt Biotherapeutics stock is owned by insiders. Learn more on BOLT's insider holdings. Which Bolt Biotherapeutics insiders have been buying company stock? The following insiders have purchased BOLT shares in the last 24 months: Sarah Nemec ($2,850.00), and William P Quinn ($9,075.00). How much insider buying is happening at Bolt Biotherapeutics? Insiders have purchased a total of 750 BOLT shares in the last 24 months for a total of $11,925.00 bought. Which Bolt Biotherapeutics insiders have been selling company stock? The following insiders have sold BOLT shares in the last 24 months: Edgar Engleman ($60,436.40), and Vivo Capital Viii, Llc ($64,724.00). How much insider selling is happening at Bolt Biotherapeutics? Insiders have sold a total of 6,765 Bolt Biotherapeutics shares in the last 24 months for a total of $125,160.40 sold. Bolt Biotherapeutics Key ExecutivesMr. William P. Quinn (Age 53)CEO, CFO, President, Secretary & Director Compensation: $610.8kMr. Grant Yonehiro C.F.A. (Age 60)M.B.A., Chief Operating Officer Compensation: $564.65kMs. Sarah Nemec (Age 48)VP of Finance & Principal Accounting Officer Mr. Wesley BurwellVP & Head of Human ResourcesDr. Nathan Ihle Ph.D.Senior Vice President of Pharmaceutical OperationsDr. Dawn Colburn BCOPPharm.D., Senior Vice President of Clinical DevelopmentDr. Michael N. Alonso Ph.D.Senior Vice President of Research More Insider Trading Tools from MarketBeat Related Companies SAB Biotherapeutics Insider Trades Molecular Templates Insider Trades Amgen Insider Trades Gilead Sciences Insider Trades Vertex Pharmaceuticals Insider Trades Regeneron Pharmaceuticals Insider Trades Alnylam Pharmaceuticals Insider Trades Biogen Insider Trades Incyte Insider Trades United Therapeutics Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months3 Small Caps Drawing Insider and Institutional SupportDo They Know Something? Insiders & Congress Buy UnitedHealth This page (NASDAQ:BOLT) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredNew crypto laws coming. Will you win or lose?Washington’s first-ever “Crypto Week” could trigger a major Bitcoin surge — but one trader says don’t just buy...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | Sponsored“All the land that you see I will give to you and your offspring forever…”“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bolt Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bolt Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
